ITGR
Integer Holdings Corp
$91.89
-0.10%
$3.1B
No data for this timeframe.
Vol
Market Cap$3.1B
Cap SizeMid Cap
Analyst ConsensusBuy (65%)
Inst. Holders7 funds
Inst. Value$485.4M
Inst. Activity0 buys / 3 sells
Insider Activity0B / 1S
Insider Net $-$70.1K
SEC Reports2
Press Releases1
Exchange NYSE·Sector Electromedical & Electrotherapeutic Apparatus·Inc. DE·CIK 0001114483·Prev Close $91.98
Recent Activity
Jun 3, 2026
contract
Integer to Participate in Truist Securities 2026 MedTech Conference on June 16
<p>PLANO, Texas, June 03, 2026 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a le
May 22, 2026
SEC
Integer Holdings Corp filed an 8-K detailing key compensation and governance actions tied to a previously announced stra
8-K — Impact 4/10
May 20, 2026
Insider
Hinrichs James F. sold 1,967 shares
Director @ $0.00 ($0.00)
May 20, 2026
Insider
Spence Donald J sold 2,623 shares
Director @ $0.00 ($0.00)
May 20, 2026
Insider
Flanagan James Francis sold 1,967 shares
Director @ $0.00 ($0.00)
Mar 12, 2026
SEC
Analysis based on filing metadata only — document content was unavailable. The 8-K reports entry into a material agreeme
8-K — Impact 4/10
Inst.
FMR LLC — TRIM
254,310 shares ($19.9M)
Inst.
TWO SIGMA INVESTMENTS, LP — TRIM
74,864 shares ($5.9M)
Price Targets
$97.56
+3.7% upside
Hold
Current $94.10
Low $84.00
Median $97.00
High $115.00
9 analysts
$84.00
$115.00
Analyst Ratings
3Strong Buy
8Buy
6Hold
0Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| May 28, 2026 | Citigroup | MAINTAIN | Neutral → Neutral |
| May 13, 2026 | Oppenheimer | UPGRADE | Perform → Outperform |
| May 1, 2026 | Citigroup | MAINTAIN | Neutral → Neutral |
| May 1, 2026 | Piper Sandler | REITERATE | Overweight → Overweight |
| Feb 20, 2026 | Citigroup | MAINTAIN | Neutral → Neutral |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $1.38 ▼ -10.3% | $1.30 — $1.43 | -11% YoY | 8 |
| Next Q | $1.69 ▼ -8.1% | $1.62 — $1.75 | -6% YoY | 8 |
| Current FY | $6.08 ▼ -6.3% | $5.90 — $6.20 | -5% YoY | 9 |
| Next FY | $6.81 ▼ -5.8% | $6.49 — $6.96 | 12% YoY | 8 |
Latest Reports
NEUTRAL
8-K
4/10
Integer Holdings Corp filed an 8-K detailing key compensation and governance actions tied to a previously announced stra
May 22, 2026
NEUTRAL
8-K
4/10
Analysis based on filing metadata only — document content was unavailable. The 8-K reports entry into a material agreeme
Mar 12, 2026
NEUTRAL
Press
4/10
Integer Holdings Corporation appointed two new independent directors, James Flanagan and Aaron Kapito, following a coope
Mar 12, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| VANGUARD GROUP INC | $304.8M | — |
| MORGAN STANLEY | $65.2M | — |
| CHARLES SCHWAB INVESTMENT MANAGEMENT | $34.3M | NEW |
| BANK OF AMERICA CORP | $34.2M | DOUBLED |
| WELLS FARGO & COMPANY/MN | $21.0M | DOUBLED |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| May 20, 2026 | Hinrichs James | A | $0.00 |
| May 20, 2026 | Spence Donald | A | $0.00 |
| May 20, 2026 | Flanagan James | A | $0.00 |
| May 20, 2026 | PASSERINI FILIPPO | A | $0.00 |
| May 20, 2026 | Antrum Sheila | A | $0.00 |
7 institutional holders with $485.4M total value (6,188,964 shares) as of 2025-Q4. Top holders: VANGUARD, MORGAN, CHARLES. Net selling activity: 3 institutions trimmed/exited vs 0 added.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 3,886,150 | $304.8M | 62.8% | — |
| 2 | MORGAN STANLEY | 831,116 | $65.2M | 13.4% | — |
| 3 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 437,964 | $34.3M | 7.1% | NEW |
| 4 | BANK OF AMERICA CORP /DE/ | 436,543 | $34.2M | 7.1% | DOUBLED +115.5% |
| 5 | WELLS FARGO & COMPANY/MN | 268,017 | $21.0M | 4.3% | DOUBLED +101.7% |
| 6 | FMR LLC | 254,310 | $19.9M | 4.1% | TRIM -59.9% |
| 7 | TWO SIGMA INVESTMENTS, LP | 74,864 | $5.9M | 1.2% | TRIM -31.5% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| FMR LLC | TRIM | 633,588 | 254,310 | -59.9% | $19.9M | 2025-Q4 |
| TWO SIGMA INVESTMENTS, LP | TRIM | 109,365 | 74,864 | -31.5% | $5.9M | 2025-Q4 |
| RENAISSANCE TECHNOLOGIES LLC | EXIT | 32,500 | 0 | -100.0% | $0.00 | 2025-Q4 |
| TWO SIGMA INVESTMENTS, LP | TRIM | 217,433 | 109,365 | -49.7% | $11.3M | 2025-Q3 |
| RENAISSANCE TECHNOLOGIES LLC | NEW | — | 32,500 | — | $3.4M | 2025-Q3 |
| BANK OF AMERICA CORP /DE/ | DOUBLED | 217,519 | 468,850 | +115.5% | $57.7M | 2025-Q2 |
| WELLS FARGO & COMPANY/MN | DOUBLED | 144,463 | 291,312 | +101.7% | $35.8M | 2025-Q2 |
| TWO SIGMA INVESTMENTS, LP | DOUBLED | 70,328 | 217,433 | +209.2% | $26.7M | 2025-Q2 |
| UBS Group AG | DOUBLED | 41,824 | 780,539 | +1766.2% | $92.1M | 2025-Q1 |
| FMR LLC | TRIM | 932,637 | 639,422 | -31.4% | $75.5M | 2025-Q1 |
| TWO SIGMA INVESTMENTS, LP | DOUBLED | 15,957 | 70,328 | +340.7% | $8.3M | 2025-Q1 |
| CITADEL ADVISORS LLC | ADD | 26,347 | 39,460 | +49.8% | $4.7M | 2025-Q1 |
| UBS Group AG | DOUBLED | 7,859 | 41,824 | +432.2% | $5.5M | 2024-Q4 |
| CITADEL ADVISORS LLC | TRIM | 49,903 | 26,347 | -47.2% | $3.5M | 2024-Q4 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | NEW | — | 404,029 | — | $52.5M | 2024-Q3 |
19 unique insiders with 1 transactions. Net insider value: -$70.1K ($0.00 bought, $70.1K sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 20, 2026 | Hinrichs James F. | Director | A | 1,967 | $0.00 | $0.00 |
| May 20, 2026 | Spence Donald J | Director | A | 2,623 | $0.00 | $0.00 |
| May 20, 2026 | Flanagan James Francis | Director | A | 1,967 | $0.00 | $0.00 |
| May 20, 2026 | PASSERINI FILIPPO | Director | A | 1,967 | $0.00 | $0.00 |
| May 20, 2026 | Antrum Sheila | Director | A | 1,967 | $0.00 | $0.00 |
| May 20, 2026 | Kapito Aaron | Director | A | 1,967 | $0.00 | $0.00 |
| May 20, 2026 | Jeffers Alvin Tyrone | Director | A | 1,967 | $0.00 | $0.00 |
| May 20, 2026 | Capps Cheryl C | Director | A | 1,967 | $0.00 | $0.00 |
| May 20, 2026 | COYLE MICHAEL J | Director | A | 1,967 | $0.00 | $0.00 |
| May 20, 2026 | MAXWELL MARTIN C | Director | A | 1,967 | $0.00 | $0.00 |
| May 18, 2026 | Thomas Tommy P | VP, Corporate Controller | A | 666 | $0.00 | $0.00 |
| May 15, 2026 | Stephens Jim | President, CRM & Neuro | F | 479 | $88.16 | $42.2K |
| May 15, 2026 | Stephens Jim | President, CRM & Neuro | M | 491 | $0.00 | $0.00 |
| May 15, 2026 | Stephens Jim | President, CRM & Neuro | M | 491 | $0.00 | $0.00 |
| May 8, 2026 | Smith Diron | EVP, Chief Financial Officer | M | 2,063 | $0.00 | $0.00 |
| May 8, 2026 | Smith Diron | EVP, Chief Financial Officer | F | 503 | $88.12 | $44.3K |
| May 8, 2026 | Smith Diron | EVP, Chief Financial Officer | M | 2,063 | $0.00 | $0.00 |
| Mar 31, 2026 | Harris John A | EVP, Global Ops and Manufactur | M | 3,837 | $0.00 | $0.00 |
| Mar 31, 2026 | Harris John A | EVP, Global Ops and Manufactur | M | 3,837 | $0.00 | $0.00 |
| Mar 31, 2026 | Harris John A | EVP, Global Ops and Manufactur | F | 1,842 | $88.00 | $162.1K |
| Mar 24, 2026 | Blackwood Lindsay K. | SVP, Gen Counsel & Secretary | M | 1,777 | $0.00 | $0.00 |
| Mar 24, 2026 | Carr Terence | EVP, Qlty & Regulatory Affairs | M | 1,350 | $0.00 | $0.00 |
| Mar 24, 2026 | Carr Terence | EVP, Qlty & Regulatory Affairs | F | 398 | $86.19 | $34.3K |
| Mar 24, 2026 | Carr Terence | EVP, Qlty & Regulatory Affairs | M | 1,350 | $0.00 | $0.00 |
| Mar 24, 2026 | Blackwood Lindsay K. | SVP, Gen Counsel & Secretary | M | 1,777 | $0.00 | $0.00 |
| Mar 24, 2026 | Blackwood Lindsay K. | SVP, Gen Counsel & Secretary | F | 1,049 | $86.19 | $90.4K |
| Mar 13, 2026 | Thomas Tommy P | VP, Corporate Controller | SELL | 825 | $85.00 | $70.1K |
| Mar 12, 2026 | Kapito Aaron | Director | A | 410 | $0.00 | $0.00 |
| Mar 12, 2026 | Flanagan James Francis | Director | A | 410 | $0.00 | $0.00 |
| Feb 24, 2026 | Khales Payman | President & CEO | M | 16,077 | $0.00 | $0.00 |
| Feb 24, 2026 | Khales Payman | President & CEO | M | 16,077 | $0.00 | $0.00 |
| Feb 20, 2026 | Stephens Jim | President, CRM & Neuro | A | 2,691 | $0.00 | $0.00 |
| Feb 20, 2026 | Smith Diron | EVP, Chief Financial Officer | A | 798 | $0.00 | $0.00 |
| Feb 20, 2026 | Senn Andrew | President, Cardio & Vascular | A | 2,340 | $0.00 | $0.00 |
| Feb 20, 2026 | Khales Payman | President & CEO | A | 7,389 | $0.00 | $0.00 |
| Feb 20, 2026 | Thomas Tommy P | VP, Corporate Controller | A | 923 | $0.00 | $0.00 |
| Feb 20, 2026 | Thor Kirk K | Chief Human Resources Officer | A | 4,475 | $0.00 | $0.00 |
2 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 0 mixed, 2 neutral. Avg impact: 4.0/10.
Current analyst consensus: Buy (65% buy). Based on 17 analysts: 3 strong buy, 8 buy, 6 hold, 0 sell, 0 strong sell.
Analyst Price Targets
$97.56 mean target
+3.7% upside
Hold (2.00)
$84.00 Low
$115.00 High
| Metric | Value |
|---|---|
| Current Price | $94.10 |
| Target Low | $84.00 |
| Target Mean | $97.56 |
| Target Median | $97.00 |
| Target High | $115.00 |
| # Analysts | 9 |
| Recommendation | Hold (2.00) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$1.38 | $1.30 | $1.43 | -10.9% | -10.3% | 0↑ 8↓ | $0.5B | -5.5% | 8 |
| Next Q 2026-09-30 |
$1.69 | $1.62 | $1.75 | -5.8% | -8.1% | 0↑ 8↓ | $0.5B | -2.1% | 8 |
| Current FY 2026-12-31 |
$6.08 | $5.90 | $6.20 | -5.0% | -6.3% | 0↑ 9↓ | $1.8B | -2.0% | 9 |
| Next FY 2027-12-31 |
$6.81 | $6.49 | $6.96 | 11.9% | -5.8% | 0↑ 8↓ | $1.9B | 5.9% | 8 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $1.381 | |
| 7d ago | $1.381 | |
| 30d ago | $1.539 | -0.158 |
| 60d ago | $1.539 | -0.158 |
| 90d ago | $1.528 | -0.147 |
6 analyst firms have rated this stock: 2 upgrades, 0 downgrades, 0 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| May 28, 2026 | Citigroup | MAINTAIN | Neutral | Neutral |
| May 13, 2026 | Oppenheimer | UPGRADE | Perform | Outperform |
| May 1, 2026 | Citigroup | MAINTAIN | Neutral | Neutral |
| May 1, 2026 | Piper Sandler | REITERATE | Overweight | Overweight |
| Feb 20, 2026 | Citigroup | MAINTAIN | Neutral | Neutral |
| Feb 20, 2026 | Wells Fargo | MAINTAIN | Equal-Weight | Equal-Weight |
| Feb 20, 2026 | Benchmark | UPGRADE | Hold | Buy |
| Feb 20, 2026 | Truist Securities | MAINTAIN | Buy | Buy |
| Dec 18, 2025 | Truist Securities | MAINTAIN | Buy | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 3 | 8 | 6 | 0 | 0 | 65% | |
| May 1, 2026 | 2 | 8 | 7 | 0 | 0 | 59% | |
| Apr 1, 2026 | 2 | 8 | 7 | 0 | 0 | 59% | |
| Mar 1, 2026 | 2 | 8 | 7 | 0 | 0 | 59% | |
| Feb 1, 2026 | 2 | 7 | 8 | 0 | 0 | 53% | |
| Jan 1, 2026 | 2 | 7 | 8 | 0 | 0 | 53% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
Jun 3, 2026
contract
Integer to Participate in Truist Securities 2026 MedTech Conference on June 16
<p>PLANO, Texas, June 03, 2026 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device contract development and manu
Apr 30, 2026
earnings
Integer Holdings Corporation Reports First Quarter 2026 Results
<p align="center"><em>~ First quarter results in line with February outlook ~</em></p>
Apr 30, 2026
short_volume
Short Volume: ITGR — 82.1% short (0.6M / 0.8M)
Short: 630,873 | Exempt: 3 | TRF Vol: 768,578 | Short Ratio: 82.1% | Off-exchange volume (dark pool + OTC)
Apr 30, 2026
earnings_calendar
ITGR Q1 2026 Earnings Scheduled — 2026-04-30
Apr 6, 2026
contract
Integer Announces Board Leadership Transition
<p>PLANO, Texas, April 06, 2026 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading global medical device contract development
Mar 19, 2026
short_interest
FTD: ITGR — 110,855 shares ($9.4M) failed to deliver
Settlement: 20260319, Price: $84.70, FTD Value: $9,389,418.5, INTEGER HLDGS CORP COM (DE)
Mar 12, 2026
contract
Integer Appoints James Flanagan and Aaron Kapito to Board of Directors
<p align="left">PLANO, Texas, March 12, 2026 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading global medical device contract
Mar 6, 2026
short_interest
FTD: ITGR — 6,693 shares ($0.6M) failed to deliver
Settlement: 20260306, Price: $85.23, FTD Value: $570,444.39, INTEGER HLDGS CORP COM (DE)
Feb 12, 2026
short_interest
FTD: ITGR — 20,294 shares ($1.8M) failed to deliver
Settlement: 20260212, Price: $87.18, FTD Value: $1,769,230.92, INTEGER HLDGS CORP COM (DE)
Feb 11, 2026
short_interest
FTD: ITGR — 16,129 shares ($1.4M) failed to deliver
Settlement: 20260211, Price: $86.15, FTD Value: $1,389,513.35, INTEGER HLDGS CORP COM (DE)